Factor V Leiden Mutation Test: Risks & Results

Understanding the Factor V Leiden Mutation

In my clinical practice, I often encounter patients who have experienced an unexpected deep vein thrombosis (DVT) or pulmonary embolism (PE) at a young age, or who have a strong family history of clotting disorders. One of the most common inherited causes I see is the Factor V Leiden mutation. This is a genetic variation that makes your blood more prone to clot, but it's important to know that having the mutation does not guarantee you'll develop a clot.

What Is Factor V Leiden?

Factor V is a protein your body produces that helps blood clot normally. The Factor V Leiden mutation is a specific change in the F5 gene. This change makes Factor V resistant to being inactivated by a natural anticoagulant called activated protein C (APC). As a result, the clotting process continues longer than it should, increasing your risk for abnormal clots, particularly in the veins of the legs (DVT) or lungs (PE).

How Is the Test Performed?

Diagnosis is done through a simple blood test that looks for the specific genetic mutation. It can also be detected using a functional test called an activated protein C resistance (APC-R) assay. The genetic test is the gold standard and is performed once in a lifetime because the mutation is present from birth and does not change.

Who Should Be Tested for Factor V Leiden?

Testing is not recommended for everyone. In my experience, it is most valuable for:

• Individuals who have had a first DVT or PE before age 50.
• Women who have recurrent miscarriages or pregnancy complications linked to clotting.
• People with a strong family history of venous thromboembolism (VTE).
• Patients who develop a clot in an unusual location (e.g., cerebral vein, portal vein).

Routine screening of the general population is not advised because many carriers never develop clots, and knowing the mutation can cause unnecessary worry.

Understanding Your Results

The test result will indicate one of three possibilities:

The risk is highest when other factors are present, such as surgery, pregnancy, oral contraceptive use, or prolonged immobility.

What Does Heterozygous vs. Homozygous Mean?

If you are heterozygous, you have one normal copy of the Factor V gene and one mutated copy. This is the most common form among affected individuals. Homozygous means both copies are mutated – this is much rarer and carries a significantly higher clotting risk.

Is Factor V Leiden Dangerous?

Most people with the mutation live their entire lives without a clot. The danger arises when the mutation is combined with additional risk factors. For example, women who carry the mutation and take oral contraceptives have a 30–50 times higher risk of DVT compared to women without the mutation. Similarly, surgery or pregnancy can trigger a clot in carriers.

Factor V Leiden and Pregnancy

Pregnant women with Factor V Leiden have an increased risk of DVT, especially after delivery. There is also a higher chance of complications such as preeclampsia, placental abruption, and recurrent miscarriage. My patients with the mutation are often managed with low-molecular-weight heparin during pregnancy and for six weeks postpartum. This significantly reduces the risk without harming the baby.

Can Factor V Leiden Be Treated?

The mutation itself cannot be 'fixed' – it's in your DNA. Treatment focuses on preventing and managing clots. Options include:

• Anticoagulant medications (blood thinners) like warfarin, heparin, or direct oral anticoagulants (DOACs) for those who have had a clot.
• Prophylactic anticoagulation during high-risk periods (surgery, pregnancy, long-haul flights).
• Lifestyle measures: staying active, maintaining a healthy weight, avoiding smoking, and staying hydrated during travel.

There is no need for lifelong treatment if you have never had a clot and have no additional risk factors.

FAQs About Factor V Leiden Mutation